Ceftolozane-tazobactam Versus Meropenem for ESBL and AmpC-producing Enterobacterales Bloodstream Infection
Clinical trial NCT04238390 · WITHDRAWN
Trial details
- NCT number
- NCT04238390
- Sponsor
- The University of Queensland
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2024-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.